[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

GlaxosmithklinePlc in Consumer Health (World)

September 2019 | 40 pages | ID: G1A712A22933EN
Euromonitor International Ltd

US$ 572.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In August 2019, GlaxoSmithKline Plc (GSK) announced the final approval of its joint venture with Pfizer Inc, creating an unrivalled consumer health powerhouse with a leadership position in OTC drugs in six of seven regions worldwide. This profile will examine the effects of this joint venture on the competitive landscape in consumer health, where GSK stands to benefit, and where the merged company can still seek value and sales growth in an increasingly consolidated industry.

Euromonitor International’s GlaxosmithklinePlc in Consumer Health (World) Company Profile offers detailed strategic analysis of the company’s business, examining its performance in the Consumer Health industry. The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
SCOPE of the report
Introduction
State of Play
Exposure to Future Growth
Competitive Positioning
Analgesics
Vitamins and Dietary Supplements
Cough, Cold and Allergy (Hay Fever) Remedies
Key Findings
Appendix


More Publications